Cephalon chairman takes leave of absence

pharmafile | September 2, 2010 | Appointment | Research and Development, Sales and Marketing Cephalon, appointment, research and development, sales and marketing 

Cephalon’s chairman and chief executive Frank Baldino Jr is taking a medical leave of absence with immediate effect.

The company said he was expected to return to helm the company later this year.

Meanwhile Cephalon’s chief operating officer J Kevin Bushi will temporarily take on Frank’s responsibilities.

Advertisement

Prior to assuming the newly-created role of chief operating officer earlier this year, Mr Buchi served as the company’s chief financial officer for 14 years, and in total has been with Cephalon for almost 20 years.

William Egan, Cephalon’s presiding director, said, “Kevin has the complete confidence and full support of the board as he manages the company’s operations until Frank’s anticipated return later this year.

“In order to provide Frank and his family the privacy that they deserve, we will not be commenting further.”

Related Content

PlasmidFactory founder Dr. Martin Schleef honoured with the NRW Innovation Award 2025

The founder and long-standing CEO of PlasmidFactory, Dr. Martin Schleef, was honoured in Düsseldorf with …

AAX Biotech announces collaboration for cardiovascular antibody therapy

Swedish biotech firm AAX Biotech has entered a new collaboration focused on the development of …

Research finds tablet effective in slowing progression of Alzheimer’s disease over 18 months

TauRx Pharmaceutics reports that hydromethylthionine mesylate (HMTM) could be an oral treatment for slowing the …

The Gateway to Local Adoption Series

Latest content